Ignite Creation Date:
2025-12-24 @ 6:55 PM
Ignite Modification Date:
2025-12-30 @ 1:24 AM
Study NCT ID:
NCT04432857
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-27
First Post:
2020-06-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
AN0025 and Pembrolizumab Combination in Advanced Solid Tumors
Sponsor:
Adlai Nortye Biopharma Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-06-11
First Submit QC Date:
None
Study First Post Date:
2020-06-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-26
Last Update Post Date:
2024-06-27
Last Update Post Date Type:
ACTUAL